Vorasidenib-Induced Trichomegaly and Hypertrichosis: a New Side Effect in a Patient with Diffuse Astrocytoma

Abstract Vorasidenib, an oral dual inhibitor targeting mutant enzymes isocitrate dehydrogenase 1 and 2, is utilized in the management of diffuse low-grade gliomas. Despite limited documentation of its adverse events, we present the case of a 44-year-old male who exhibited trichomegaly and hypertrich...

Full description

Bibliographic Details

Published in:	Dermatology and Therapy
Main Authors:	Michela Starace, Stephano Cedirian, Luca Rapparini, Francesca Bruni, Bianca Maria Piraccini
Format:	Article
Language:	English
Published:	Adis, Springer Healthcare 2024-08-01
Subjects:	Vorasidenib Trichomegaly Hypertrichosis Oncology therapy Astrocytoma Side effect
Online Access:	https://doi.org/10.1007/s13555-024-01263-4